Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
about
Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle.Cardiovascular magnetic resonance in systemic hypertensionHypertensive heart disease: MR tissue phase mapping reveals altered left ventricular rotation and regional myocardial long-axis velocities.Speckle-tracking and tissue-Doppler stress echocardiography in arterial hypertension: a sensitive tool for detection of subclinical LV impairmentMyocardial function in aortic stenosis--insights from radial multilayer Doppler strain.Relation of torsion and myocardial strains to LV ejection fraction in hypertension.A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.Regional Heterogeneity in 3D Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy: A Cardiovascular CMR Tagging Substudy to the Life Study.Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study.The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality.Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach.Generalized spatiotemporal myocardial strain analysis for DENSE and SPAMM imaging.Comparison of local sine wave modeling with harmonic phase analysis for the assessment of myocardial strain.
P2860
Q30458877-0D911617-3BD8-412C-85E5-E717CC5DB4FFQ30466693-34A86A9C-0659-48C9-A310-B60F3BB6F3F1Q34377343-544C6226-D9A2-4C7A-AE80-7BAF76B0AA63Q34426171-11BB24B3-9AF1-4509-9A3C-768C21FDC9D5Q35122751-9978B6BC-D1F9-4466-B089-ADC925318C01Q35876106-D3E02BBC-2B4E-438C-8CE6-107F6EC0CA01Q36088471-6461CF8C-4F3F-4746-A96E-6AE6C5A97D2CQ36708353-2B07D4D2-5E59-4AA2-878F-9270343E6AFCQ43203700-6768021E-0F19-4578-AEC9-97232090C7E8Q45825542-8BBC1E3B-051E-45F3-9326-283E687E373CQ48685609-FC6DB7DA-3BE2-4F55-A4DB-65C32A3AA19EQ51483882-02594E57-10A9-44F4-BF3A-538355AE5C13Q53128583-07450CEB-C117-4D2C-A788-3A811D81D539
P2860
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Marked regional left ventricul ...... nd echocardiographic substudy.
@en
Marked regional left ventricul ...... oint reduction in hypertension
@nl
type
label
Marked regional left ventricul ...... nd echocardiographic substudy.
@en
Marked regional left ventricul ...... oint reduction in hypertension
@nl
prefLabel
Marked regional left ventricul ...... nd echocardiographic substudy.
@en
Marked regional left ventricul ...... oint reduction in hypertension
@nl
P2093
P2860
P1433
P1476
Marked regional left ventricul ...... nd echocardiographic substudy.
@en
P2093
David Calhoun
Eduardo Kortright
Gerald M Pohost
Gilbert Perry
Jonathan N Bella
Louis J Dell'Italia
Mark Doyle
Robert W W Biederman
Suzanne Oparil
P2860
P304
P356
10.1161/HYPERTENSIONAHA.108.109819
P407
P577
2008-07-07T00:00:00Z